TR200102850T2 - Depresyonun iyileçtirilmesi i‡in gaba analoglarì ve trisiklik bileçiklerin kombinasyonlarì - Google Patents

Depresyonun iyileçtirilmesi i‡in gaba analoglarì ve trisiklik bileçiklerin kombinasyonlarì

Info

Publication number
TR200102850T2
TR200102850T2 TR2001/02850T TR200102850T TR200102850T2 TR 200102850 T2 TR200102850 T2 TR 200102850T2 TR 2001/02850 T TR2001/02850 T TR 2001/02850T TR 200102850 T TR200102850 T TR 200102850T TR 200102850 T2 TR200102850 T2 TR 200102850T2
Authority
TR
Turkey
Prior art keywords
tricyclic
bracelets
combinations
gaba analogs
improve depression
Prior art date
Application number
TR2001/02850T
Other languages
English (en)
Turkish (tr)
Inventor
Magnus Leslie
A. Saltel Douglas
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of TR200102850T2 publication Critical patent/TR200102850T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TR2001/02850T 1999-04-09 2000-02-16 Depresyonun iyileçtirilmesi i‡in gaba analoglarì ve trisiklik bileçiklerin kombinasyonlarì TR200102850T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12857199P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
TR200102850T2 true TR200102850T2 (tr) 2002-03-21

Family

ID=22435960

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02850T TR200102850T2 (tr) 1999-04-09 2000-02-16 Depresyonun iyileçtirilmesi i‡in gaba analoglarì ve trisiklik bileçiklerin kombinasyonlarì

Country Status (11)

Country Link
EP (1) EP1180058A1 (xx)
JP (1) JP2002541224A (xx)
KR (1) KR20010108466A (xx)
AU (1) AU3492900A (xx)
CA (1) CA2367494A1 (xx)
HU (1) HUP0200733A3 (xx)
IL (1) IL145736A0 (xx)
NZ (1) NZ514401A (xx)
TR (1) TR200102850T2 (xx)
WO (1) WO2000061234A1 (xx)
ZA (1) ZA200108259B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
US20060167032A1 (en) * 2002-01-16 2006-07-27 Galer Bradley S Pharmaceutical composition and method for treating disorders of the central nervous system
BRPI0414343A (pt) * 2003-09-12 2006-11-07 Pfizer combinações que compreendem ligantes de alfa-2-delta e inibidores da reabsorção de serotonina/noradrenalina
KR20060087560A (ko) * 2003-09-12 2006-08-02 워너-램버트 캄파니 엘엘씨 알파-2-델타 리간드 및 ssri 및/또는 snri를포함하는 우울증 및 불안 장애 치료용 조합물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
FR2453643A2 (fr) * 1977-06-24 1980-11-07 Synthelabo Compositions pharmaceutiques actives sur le systeme nerveux central
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
EP0726073A3 (en) * 1995-02-10 1998-07-08 Eduardo Samuel Bleiweiss Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine

Also Published As

Publication number Publication date
KR20010108466A (ko) 2001-12-07
AU3492900A (en) 2000-11-14
EP1180058A1 (en) 2002-02-20
CA2367494A1 (en) 2000-10-19
HUP0200733A3 (en) 2003-04-28
HUP0200733A2 (hu) 2002-07-29
JP2002541224A (ja) 2002-12-03
WO2000061234A1 (en) 2000-10-19
NZ514401A (en) 2003-10-31
ZA200108259B (en) 2003-03-26
IL145736A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ES2059575T3 (es) Aductos modificados de poliepoxido y polioxialquilen-poliamidas.
CR20110356A (es) Bioconversion estereoselectiva de dinitrilos alifaticos en acidos cianocarboxilicos (divisional exp. 8686)
GT199900056A (es) Nuevas dihidropirimidinas
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
ATE77960T1 (de) Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.
ATE282176T1 (de) Beleuchtungsvorrichtung für nicht-emitierende anzeige
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
AR246535A1 (es) Composicion para usarla en empaquetamiento, pared para empaquetamiento conteniendo a la misma, metodos para fabricarlas y envases, botellas y recipientes que contienen a dicha pared.
AR038437A1 (es) Tintura permanente del cabello en dos pasos
DE69841711D1 (de) Modulator der menschlichen mastzellaktivierung
DE59907378D1 (de) Selbstklebende bandage
ES2195073T3 (es) Metalocenos, su preparacion y su utilizacion en la polimerizacion de alfa-olefinas.
TR200102850T2 (tr) Depresyonun iyileçtirilmesi i‡in gaba analoglarì ve trisiklik bileçiklerin kombinasyonlarì
SE9904674D0 (sv) Novel compounds
TR200102837T2 (tr) ídrar tutamama durumunun tedavisi
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ES2055830T3 (es) Derivados de cromano.
ATE320422T1 (de) Metalloproteinase inhibitoren
MY107196A (en) Fluorogenic tryptophanase substrates.
AR031608A1 (es) Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ATE148105T1 (de) Succinoylaminohydroxyäthylaminosulfamidsäureder vate und ihre verwendung als retrovirale proteasehemmer
JPS5242681A (en) Lighting fixture
DE50015065D1 (de) Markiervorrichtung für fussgängerstreifen